ShareValue scores for ASTEC.NSE: Valuation 35, Quality 26, Growth 53, Health 45.

ASTEC.NSE
NSE

Astec LifeSciences Limited

₹620.35(+0.62%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-7% to 12%
Valuation
35
Overvalued
Price vs Value
Quality
26
Weak
Business Strength
Growth
53
Moderate
Revenue & Earnings
Health
45
Moderate
Financial Stability
Momentum
64
Bullish
Price Trend

Company Details

About

Astec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. The company provides triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservative. It also provides herbicides, insecticides, and specialty chemical products. The company also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026